Silent myocardial ischemia in patients with coronary artery disease. Possible links with diastolic left ventricular

J J Mahmarian1, C M Pratt

  • 1Department of Internal Medicine, Baylor College of Medicine, Houston, Texas.

Circulation
|February 1, 1990
PubMed

Insights

Silent myocardial ischemia, often undetected, is common in coronary artery disease. Evidence of this silent ischemia increases cardiovascular risk and impairs heart function, affecting both systolic and diastolic performance.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Diagnostic Imaging

Background:

  • Silent myocardial ischemia is a prevalent manifestation of coronary artery disease (CAD).
  • It carries significant physiological, hemodynamic, and prognostic implications.
  • Asymptomatic ST segment shifts are more common than symptomatic ones and indicate abnormal myocardial perfusion.

Purpose of the Study:

  • To highlight the prevalence and clinical significance of silent myocardial ischemia.
  • To examine the impact of ischemia on left ventricular systolic and diastolic function.
  • To assess the reversibility of diastolic dysfunction after revascularization.

Main Methods:

  • Ambulatory 24-hour electrocardiographic monitoring.
  • Exercise treadmill testing.
  • Radionuclide scintigraphy for myocardial perfusion assessment.
  • Hemodynamic studies during atrial pacing and dynamic exercise.

Main Results:

  • Asymptomatic ST shifts are frequent and linked to abnormal myocardial perfusion.
  • Silent ischemia is associated with increased cardiovascular morbidity risk in various CAD patient groups.
  • Ischemia adversely affects left ventricular systolic function.
  • Diastolic relaxation and filling are impaired by both symptomatic and asymptomatic ischemia.
  • Abnormal diastolic parameters are common at rest in CAD patients and partially reversible post-revascularization.
  • Diastolic function appears more susceptible to ischemia than systolic function.

Conclusions:

  • Silent myocardial ischemia is a critical indicator of cardiovascular risk in CAD.
  • Both systolic and diastolic cardiac functions are compromised by ischemia.
  • Diastolic dysfunction is prevalent, potentially more sensitive to ischemia, and may improve after revascularization procedures.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...